Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Brandon Ingram exits Raptors playoff game early

April 29, 2026

Motorola just revealed the Razr Fold’s price and hoo boy

April 29, 2026

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

April 29, 2026

Pure Mate Launches World’s First Botanical Wellness Diffuser with Smart LCD Tracking

April 29, 2026

Did you know Elk Island National Park has black bears?

April 29, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Drug-Eluting Balloons (DEBs) Market Assessment 2024-2030 – Rising Adoption of DEBs in Coronary Artery Disease (CAD) Treatment Expands Market Opportunities
Press Release

Drug-Eluting Balloons (DEBs) Market Assessment 2024-2030 – Rising Adoption of DEBs in Coronary Artery Disease (CAD) Treatment Expands Market Opportunities

By News RoomSeptember 5, 20244 Mins Read
Drug-Eluting Balloons (DEBs) Market Assessment 2024-2030 – Rising Adoption of DEBs in Coronary Artery Disease (CAD) Treatment Expands Market Opportunities
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) — The “Drug Eluting Balloons (DEBs) – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The global market for Drug Eluting Balloons (DEBs) was estimated at US$1.4 Billion in 2023 and is projected to reach US$3 Billion by 2030, growing at a CAGR of 9.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Acrostak Int. Distr. Sarl, B. Braun Melsungen AG, BARD (A Becton, Dickinson Company), and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Peripheral Drug Eluting Balloons segment, which is expected to reach US$1.7 Billion by 2030 with a CAGR of 8.1%. The Coronary Drug Eluting Balloons segment is also set to grow at 12.5% CAGR for the next 8-year period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $433.5 Million in 2023, and China, forecasted to grow at an impressive 9.5% CAGR to reach $534.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Drug Eluting Balloons (DEBs) Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Drug Eluting Balloons (DEBs) Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Drug Eluting Balloons (DEBs) Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Select Competitors (Total 42 Featured):

  • Acrostak Int. Distr. Sarl
  • B. Braun Melsungen AG
  • BARD (A Becton, Dickinson Company)
  • Cardionovum GmbH
  • Cook Medical, Inc.
  • Eurocor GmbH
  • Medtronic PLC
  • Spectranetics Corporation

Key Attributes

Report Attribute Details
No. of Pages 194
Forecast Period 2023-2030
Estimated Market Value (USD) in 2023 $1.4 Billion
Forecasted Market Value (USD) by 2030 $3 Billion
Compound Annual Growth Rate 9.9%
Regions Covered Global

Key Topics Covered

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • Drug Eluting Balloons (DEBs) – Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Growing Incidence of Cardiovascular Diseases Drives Demand for Drug Eluting Balloons (DEBs)
  • Increasing Focus on Minimally Invasive Procedures Strengthens Business Case for Drug Eluting Balloons
  • Expansion of Peripheral Artery Disease (PAD) Treatment Spurs Demand for DEBs in Vascular Interventions
  • Technological Innovations in Biodegradable Polymers Set the Stage for Market Growth in Drug Eluting Balloons
  • Rising Adoption of DEBs in Coronary Artery Disease (CAD) Treatment Expands Market Opportunities
  • Increasing Use of DEBs in Renal and Carotid Artery Interventions Expands Market Opportunities

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/qfhad4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Drug Eluting Balloons (DEBs) Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Pure Mate Launches World’s First Botanical Wellness Diffuser with Smart LCD Tracking

Crypto News Today: AlphaPepe Presale Crosses 8,100 Holders as Dogecoin Price Prediction Questions Whether DOGE Price Can Push to $10

Concurrent Technologies Corporation Secures $18 Million AFRL Contract to Advance Energy Storage Solutions for Air Force Missions

AI Enters the Group Chat: Startup Shapes Emerges from Stealth with $8M Seed Round, Addresses AI Psychosis with First App Where You Can Talk to AI with Friends

DXD Capital Provides Wealth Managers Access to Its Latest Self Storage Fund via iCapital Marketplace

Fathers care now more than ever, but caring has never been harder – new study reveals half of the world’s fathers and mothers feel unsupported by society as they care for loved ones

G Hughes Relaunches with Refreshed Brand Identity and New Globally Inspired Sauces

HEINEKEN strengthens global capability footprint with official opening of Business Services Centre in India

Editors Picks

Motorola just revealed the Razr Fold’s price and hoo boy

April 29, 2026

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

April 29, 2026

Pure Mate Launches World’s First Botanical Wellness Diffuser with Smart LCD Tracking

April 29, 2026

Did you know Elk Island National Park has black bears?

April 29, 2026

Latest News

Crypto News Today: AlphaPepe Presale Crosses 8,100 Holders as Dogecoin Price Prediction Questions Whether DOGE Price Can Push to $10

April 29, 2026

Concurrent Technologies Corporation Secures $18 Million AFRL Contract to Advance Energy Storage Solutions for Air Force Missions

April 29, 2026

Elon Musk’s worst enemy in court is Elon Musk

April 29, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version